Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 9
2005 10
2006 5
2007 1
2008 3
2009 1
2010 6
2011 6
2012 4
2013 5
2014 13
2015 12
2016 11
2017 8
2018 6
2019 9
2020 5
2021 5
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Moreau P, Masszi T, Grzasko N, Bahlis NJ, Hansson M, Pour L, Sandhu I, Ganly P, Baker BW, Jackson SR, Stoppa AM, Simpson DR, Gimsing P, Palumbo A, Garderet L, Cavo M, Kumar S, Touzeau C, Buadi FK, Laubach JP, Berg DT, Lin J, Di Bacco A, Hui AM, van de Velde H, Richardson PG; TOURMALINE-MM1 Study Group. Moreau P, et al. N Engl J Med. 2016 Apr 28;374(17):1621-34. doi: 10.1056/NEJMoa1516282. N Engl J Med. 2016. PMID: 27119237 Free article. Clinical Trial.
Measuring allostatic load in the workforce: a systematic review.
Mauss D, Li J, Schmidt B, Angerer P, Jarczok MN. Mauss D, et al. Among authors: schmidt b. Ind Health. 2015;53(1):5-20. doi: 10.2486/indhealth.2014-0122. Epub 2014 Sep 13. Ind Health. 2015. PMID: 25224337 Free PMC article. Review.
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial.
Harbeck N, Fasching PA, Wuerstlein R, Degenhardt T, Lüftner D, Kates RE, Schumacher J, Räth P, Hoffmann O, Lorenz R, Decker T, Reinisch M, Göhler T, Staib P, Gluz O, Schinköthe T, Schmidt M; AGO-B WSG PreCycle investigators (see Appendix 1). Harbeck N, et al. Ann Oncol. 2023 Aug;34(8):660-669. doi: 10.1016/j.annonc.2023.05.003. Epub 2023 May 16. Ann Oncol. 2023. PMID: 37201751 Free article. Clinical Trial.
Elevated RIPK3 correlates with disease burden in myelofibrosis.
Dill V, Wagner CV, Keller EC, Fernandez-Hernandez FJ, Shoumariyeh K, Odinius TO, Buschhorn L, Hauch RT, Suren C, Hecker JS, Herhaus P, Sandherr M, Schmidt B, Slotta-Huspenina J, Bassermann F, Höckendorf U, Jilg S, Branca C, Vosberg S, Jost PJ. Dill V, et al. Among authors: schmidt b. Blood Adv. 2023 Apr 11;7(7):1219-1224. doi: 10.1182/bloodadvances.2021006838. Blood Adv. 2023. PMID: 36453650 Free PMC article. No abstract available.
Hydrodynamic Electron Flow and Hall Viscosity.
Scaffidi T, Nandi N, Schmidt B, Mackenzie AP, Moore JE. Scaffidi T, et al. Among authors: schmidt b. Phys Rev Lett. 2017 Jun 2;118(22):226601. doi: 10.1103/PhysRevLett.118.226601. Epub 2017 Jun 2. Phys Rev Lett. 2017. PMID: 28621998
The HEV Ventilator: at the interface between particle physics and biomedical engineering.
Buytaert J, Collins P, Abed Abud A, Allport P, Pazos Álvarez A, Akiba K, de Aguiar Francisco OA, Bay A, Bernard F, Baron S, Bertella C, Brunner JX, Bowcock T, Buytaert-De Jode M, Byczynski W, De Carvalho R, Coco V, Collins R, Dikic N, Dousse N, Dowd B, Dreimanis K, Dumps R, Durante P, Fadel W, Farry S, Fernàndez Prieto A, Fernàndez Tèllez A, Flynn G, Franco Lima V, Frei R, Gallas Torreira A, García Chàvez T, Gazis E, Guida R, Hennessy K, Henriques A, Hutchcroft D, Ilic S, Ivanovs A, Jevtic A, Jimenez Dominguez E, Joram C, Kapusniak K, Lemos Cid E, Lindner J, Lindner R, Ivàn Martínez Hernàndez M, Meboldt M, Milovanovic M, Mico S, Morant J, Morel M, Männel G, Murray D, Nasteva I, Neufeld N, Neuhold I, Pardo-Sobrino López F, Pèrez Trigo E, Pichel Jallas G, Pilorz E, Piquilloud L, Pons X, Reiner D, Règules Medel HD, Rodríguez Ramírez S, Rodíguez Cahuantzi M, Roosens C, Rostalski P, Sanders F, Saucet E, Schmid Daners M, Schmidt B, Schoettker P, Schwemmer R, Schindler H, Sharma A, Sivakumaran D, Sigaud C, Spitas V, Steffen N, Svihra P, Tejeda Muñoz G, Tachatos N, Tsolakis E, van Leemput J, Vignaux L, Vasey F, Woonton H, Wyllie K. Buytaert J, et al. Among authors: schmidt b. R Soc Open Sci. 2022 Mar 16;9(3):211519. doi: 10.1098/rsos.211519. eCollection 2022 Mar. R Soc Open Sci. 2022. PMID: 35308626 Free PMC article.
Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis.
Momotow J, Bühnen I, Trautmann-Grill K, Kobbe G, Hahn D, Schroers R, Heinrich B, Gaska T, Forstbauer H, Schmidt B, Boger R, Hüttmann A, Heil G, Kraemer DM, Krüger W, Zeremski V, Grobe N, Jentsch-Ullrich K, Griesinger F, Fuchs M, von Tresckow B, Borchmann P, Engert A, Bröckelmann PJ. Momotow J, et al. Among authors: schmidt b. Br J Haematol. 2022 Jul;198(2):401-404. doi: 10.1111/bjh.18231. Epub 2022 May 11. Br J Haematol. 2022. PMID: 35538912 No abstract available.
120 results